Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.
Bellmann
Romuald
R
Clinical Pharmacokinetics Unit, Medical Intensive Care Research Laboratory, and Intensive Care Unit, Department of Internal Medicine, University of Innsbruck, Austria. romuald.bellmann@uibk.ac.at
Egger
Petra
P
Wiedermann
Christian J
CJ
D000666:Amphotericin B / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D006801:Humans; D050356:Lipid Metabolism; D008081:Liposomes; D009181:Mycoses / Q000378:metabolism*
D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B